ArticleTobacco induced diseases2026
Association between secondhand smoke exposure and hyperuricemia among never smokers: A cross-sectional analysis of NHANES data.
Article in Tobacco induced diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionSecondhand smoke (SHS) exposure is recognized as an important contributor to multiple adverse health outcomes, including hyperuricemia. However, the association between SHS exposure and hyperuricemia remains inconclusive. This study aimed to examine the relationship between SHS exposure and hyperuricemia using serum cotinine concentration as an objective biomarker.
methodsData were obtained from the National Health and Nutrition Examination Survey (NHANES) collected between 1999 and 2020. A cross-sectional analysis was performed among 18610 adults who self-reported never smoking (never smokers). Participants were categorized into four groups based on serum cotinine concentrations: non-exposure (<0.05 ng/mL), low-exposure (0.05-0.99 ng/mL), moderate-exposure (1-10 ng/mL), and heavy-exposure (>10 ng/mL). Associations between SHS exposure and hyperuricemia were evaluated using multivariable logistic regression analysis models and smooth curve fitting.
resultsAfter adjusting for potential confounders, the adjusted odds ratios (AOR) for hyperuricemia in the low-, moderate-, and heavy-exposure groups, compared with the non-exposure group, were 1.34 (95% CI: 1.18-1.53), 1.48 (95% CI: 1.08-2.02), and 1.97 (95% CI: 1.27-3.05), respectively. A non-linear positive saturation association was observed between log2-transformed serum cotinine concentrations and the prevalence of hyperuricemia. The inflection point was identified at approximately -3.37 ng/mL, with an AOR of 1.15 (95% CI: 1.08-1.22). Subgroup analysis revealed consistent associations across all demographic and clinical stratifications.
conclusionsAmong never smokers, SHS exposure was significantly associated with an increased risk of hyperuricemia. A threshold effect was identified at a serum cotinine concentration of -3.37 ng/mL. These findings provide a direction for further study on the relationship between SHS exposure and hyperuricemia.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.